| Name | Title | Contact Details |
|---|---|---|
Scott Robertson |
Director Information Security and Compliance | Profile |
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Retire-At-Home Services Inc is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clemex Technologies Inc. is a Longueuil, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.
Norwegian American Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chicago, IL. To find more information about Norwegian American Hospital, please visit www.nahospital.org